An outbreak of Serratia marcescens associated with the anesthetic agent propofol

American Journal of Infection Control

Volumn 29, Issue 5, 2001, Pages 312-315

  Henry, B ^a   Plante Jenkins, C ^a   Ostrowska, K ^a  

^a HEALTH CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROPOFOL;

ADOLESCENT; ADULT; AGED; ANESTHESIST; ARTICLE; ASEPSIS; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; CANADA; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROBACTER INFECTION; FEMALE; HUMAN; MALE; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR; SCHOOL CHILD; SERRATIA MARCESCENS; WOUND INFECTION;

EID: 0034797381     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1067/mic.2001.117043     Document Type: Article

References (12)

1. Postoperative Serratia marcescens wound infections traced to an out of hospital source
2. An outbreak of Serratia marcescens infections related to contaminated chlorhexidine
3. Nosocomial epidemic of Serratia marcescens septicemia ascribed to contaminated blood transfusion bags
4. Risk factors for acquisition of Serratia marcescens in a surgical intensive care unit
5. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs and attributable mortality
6. Postoperative infections traced to contamination of an intravenous anesthetic, propofol
7. Growth of microorganisms in solutions of intravenous anaesthetic agents
8. Microbial growth and endotoxin production in the intravenous anesthetic agent propofol
9. Propofol and postoperative infections
10. Growth of Escherichia coli in propofol, lidocaine and mixtures of propofol and lidocaine
11. Bacterial growth and endotoxin production in lipid emulsion
12. Growth curves of Staphylococcus aureus, Candida albicans, and Moraxella osloensis in propofol and other media